In models of myocardial ischemia/reperfusion and permanent coronary occlusion, AnxA1 limits injury, an effect in acute phases attributable to restrained leukocyte trafficking and activation [110,111]. This evidence concerns the gene ANXA1 and myocardial ischemia.